Biotech is hot. A number of sizeable deals -- and expectations of more -- keep the sector in the headlines and in the minds of investors. Here are three I've got my eye on...

The only thing better than a generous dividend is a generous and growing dividend.

I'm going to pull back the curtain on how our most successful stock-picking system works. But I'm not stopping there... I'm also going to share a list of stocks that have been "scored" by the system that's previously been available to subscribers only...

The prospect of having the best of both worlds (growth and value) rolled up into one stock is just too good to pass up. Here's what I found...

After selling early but still booking a big gain, we're getting a rare second chance with this stock.

In the search for big gains, we often forget to spend some time thinking about what to avoid. That's what we're going to look at right now...

It's one of our longest-tenured portfolio holdings -- and it's beaten the market by 50 percentage points... But it's run into trouble recently. Is it still worth owning today?

It's the best of both worlds... strong dividend payers -- but with serious price momentum.

All of these stocks have gained 100% or more in the past year -- but still have room to run. Learn about them here...

The market is showing signs of weakness, but I'm not recommending stop-loss orders for many of the aggressive growth stocks we own. Here's why...